Study reveals why TB burden is not easing
A fresh study appears to shed light on why cases of TB remain persistently high in Africa and across the world despite increasing efforts to tackle the disease.
A new report shows that over 80 percent of patients with TB, considered the world’s deadliest infections, are not exhibiting a persistent cough — which is conventionally considered to be the most common symptom of the infectious disease.
In the results published in the Lancet Infectious Diseases on March 12, researchers, led by Amsterdam UMC and the Amsterdam Institute for Global Health and Development, data on more than 600,000 persons in Africa and Asia showed that 82.8 percent of those with tuberculosis had no persistent cough and 62.5 percent had no cough at all.
“Cough has for long been perceived as the primary mechanism by which tuberculosis is transmitted, although recent bioaerosol studies suggest that cough is not needed for expelling bacilli,” say the scientists.
The study, which was carried out between 2007 and 2020 showed that a quarter of those without cough had high loads of bacteria in their sputum and were probably highly infectious.
Yet in many TB control programmes, persistent cough is the primary symptom that sets off the diagnostic process for HIV-negative patients presenting at health facilities.
“This raises the possibility that those who have tested negative may be unknowingly transmitting the infection.”
The team found 21 percent of detected TB patients without persistent cough and 18 percent of patients without any cough had a positive sputum smear. Smear-positive TB is 4–5 times more contagious than smear-negative TB.
The results give a probable explanation as to why despite huge efforts to diagnose and treat the disease, the TB burden in Africa and Asia is not declining.
“We already knew there was a giant gap between the 10.6 million who get ill with TB and the 7.5 million cases that were registered by health authorities in 2022,” says Frank Cobelens, Professor of Global Health at Amsterdam UMC and Senior Fellow at the AIGHD.
“A persistent cough is often the entry point for a diagnosis, but if 80 percent of those with TB don’t have one, it means that a diagnosis will happen later, possibly after the infection has already been transmitted to many others,” he added.
In high-incidence settings, this could contribute considerably to disease transmission and to the TB burden.
The study analysed the results of national monitoring schemes in 12 countries, and found that, alongside the lack of a cough, more than a quarter of those with TB had no symptoms at all. With both of these traits being more common in women than in men.
“When we take all of these factors into account, it becomes clear that we need to really rethink large aspects of how we identify people with TB. It’s clear that current practice, especially in the most resource-poor settings will miss large numbers of patients with TB. We should instead focus on X-ray screening and the development of new inexpensive and easy-to-use tests,” says Cobelens.
Read also: The MTN, Mastercard e-commerce deal eyeing consumers in 16 African countries
TB symptoms
Over the past few decades, significant strides have been made in the diagnosis and treatment of TB. However, out of an estimated 10.6 million people worldwide who fell ill with TB in 2022, only 7.5 million cases were notified with the 3·1 million difference largely reflecting patients who were not diagnosed.
Part of this diagnostic gap might be missed diagnoses in people with TB pathology who do not report tuberculosis-suggestive symptoms.
Consequently, this could serve as a significant factor leading to delayed or overlooked diagnosis, thus contributing to the lower-than-expected impact of tuberculosis control initiatives on the global TB incidence in recent decades.
According to the Kenya TB Dashboard by StopTB.org, in 2020, Kenya had an estimated 139,000 people develop TB, with 17,000 of these cases being children. There were also approximately 35,000 estimated cases of TB co-infected with HIV and about 21,000 deaths due to TB.
Kenya has identified TB as the fourth leading cause of death among communicable, maternal, neonatal, and nutritional diseases. The TB burden in Kenya is compounded by challenges such as multidrug-resistant TB, which poses a significant health security threat and risks undermining the gains made in the fight against TB.
The disease’s economic burden is also profound, with a huge number of drug-resistant TB patients losing their jobs due to illness. Kenya also faces challenges in terms of inadequate testing facilities and the cost management of TB treatment.
In Africa, TB is the second leading cause of death from a single infectious agent, surpassing the toll of HIV and Aids. This is because, four in every five people are carrying undetected tuberculosis (TB), facilitating its spread and presenting significant challenges for tuberculosis control efforts, scientists have said.
In 2022, some 2.5 million individuals on the continent contracted the disease, equating to one person every 13 seconds, and representing a quarter of all new TB cases globally.
Africa accounts for over 33 percent of all TB-related deaths in 2022, with an estimated 424,000 deaths of the 1.267 million total global deaths.
